Search NLS News

Cyxone has announced results from its ongoing collaboration with Medical University of Vienna. Cyxone and its research partner, the Medical University of Vienna, announced pre-clinical data further supporting T20K as a treatment for MS in combination with a kappa opioid receptor agonist (KORa). Strong preclinical results Previously Cyxone announced efficacy of T20K/KORa drug combination in […]

Aqilion has nominated Girtab, a program from the company’s research activities, for further preclinical and clinical development. The goal of Girtab is to develop a new treatment for chronic inflammatory bowel diseases (IBD). Girtab complements Aqilion’s pipeline well and strengthens the company’s strategic focus on drug targets and programs with great potential in inflammatory diseases, […]

Prevas has signed an agreement for the acquisition of 100 percent of BitSim NOW AB, a subsidiary of Vironova. BitSim NOW is a consulting firm in Stockholm with 35 employees focusing on innovative product development. Examples of areas of strength are digital cameras, image processing and vision technology as well as FPGA circuit development. Customers […]

Sidekick Health has raised 55 million USD in Series B funding. The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, as well as a US-based strategic investor that will be revealed at a later stage. Read more: Filling a void in chronic […]

Immunicum has announced the appointment of Leopold Bertea as Chief Technology Officer (CTO), effective as of May 5, 2022. In his role as CTO at Immunicum, Bertea will be driving the build-up of a global manufacturing infrastructure for Immunicum’s lead pipeline program, DCP-001, which is currently progressing through a Phase II clinical study. Additionally, he […]

AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi, in combination with standard-of-care chemotherapy, has been accepted and granted Priority Review in the US for patients with locally advanced or metastatic biliary tract cancer (BTC). The Food and Drug Administration (FDA) grants Priority Review to applications for medicines that, if approved, would offer significant improvements over […]

Ilya Pharma has announced the appointments of Dr Melya Hughes Crameri and William (Bill) Carson to the Board of Directors. The appointments come as the company approaches key stages in the development of its portfolio of three immunotherapies for skin and mucosal diseases, it states. “I am delighted to welcome Melya and Bill to the […]

BioInvent International receives a milestone payment from Bayer/Hope Medicine following clinical progression of an out-licensed antibody. BioInvent receives EUR 500,000 following the enrollment of the first patient in a Phase 2 trial of HMI-115 for the treatment of endometriosis in pre-menopausal women. HMI-115 is an anti-prolactin receptor antibody discovered using BioInvent’s n-CoDeR phage display antibody […]

The two collaborators have signed an agreement with the aim to advance genomics and precision medicine and its implementation in healthcare. The joint partnership will focus on the development and implementation of innovative solutions and models to provide genomic-based precision medicine at a national level, state the collaborators. “Denmark and Sweden have many similarities in […]

Scientists at deCODE genetics have together with their Nordic collaborators published the largest genome-wide association study to date on rheumatoid arthritis (RA), including over thirty thousand cases and one million controls. The study is based on an extensive collaboration between researchers in six northwestern European countries and includes information on not only RA overall but […]